Mechanism-based treatment of acne vulgaris: the value of combination therapy

Journal of Drugs in Dermatology, May-June, 2005 by Guy Webster

11. Gollnick H. Current perspectives in the treatment of acne vulgaris and implications for future directions. J Eur Acad Dermatol Venereol. 2001;15(suppl 3):1-4.

12. Vega B, Jomard A, Michel S. Toll-like receptor A: a novel mechanism of action of adapalene in the treatment of inflammatory acne lesions. Poster P84, American Academy of Dermatology 61st Annual Meeting. March 21-26, San Francisco, CA.

13. Duvic M. Pharmacologic profile of tazarotene. Cutis. 1998;61(suppl 2):22-26.

14. Leyden JJ. Current issues in antimicrobial therapy for the treatment of acne. J Eur Acad Dermatol Venereol. 2001;15(suppl 3):51-55.

15. Webster GF, McGinley KJ, Leyden JJ. Inhibition of lipase production in Propionibacterium acnes by subminimal-inhibitory concentrations of tetracycline and erythromycin. Br J Dermatol. 1981;105:453-457.

16. Webster GF, Leyden JJ, McGinley KJ, McArthur WP. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin. Antimicrob Agents Chemother. 1982;21:770-772.

17. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: lesions from Europe. Br J Dermatol. 2003;148:467-478.

18. Eady EA, Gloor M, Leyden JJ. Propionibacterium acnes resistance: a worldwide problem. Dermatology. 2003;206:54-56.

19. Adams SJ, Cunliffe WJ, Cooke EM. Long-term antibiotic therapy for acne vulgaris: effects on the bowel flora of patients and their relatives. J Invest Dermatol. 1985;85:35-37.

20. Levy RM, Huang EY, Roling D, Leyden JJ, Margolis DJ. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol. 2003;139:467-471.

21. Velicer CM, Heckbert SR, Lampe JW, et al. Antibiotic use in relation to the risk of breast cancer. JAMA. 2004;291(7):827-35.

22. Hegemann L, Toso SM, Kitay K, Webster GF. Anti-inflammatory actions of benzoyl peroxide: effects on the generation of reactive oxygen species by leucocytes and the activity of protein kinase C and calmodulin. Br J Dermatol. 1994;130:569-575.

23. Martin B, Meunier C, Montels D. Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. Br J Dermatol. 1998;139(Suppl 52):8-11.

24. Nyirady J, Lucas C, Yusuf M, et al. The stability of tretinoin in tretinoin gel microsphere 0.1%. Cutis. 2002;70(50:295-8.

25. Yaroshinsky A, Leyden J. The safety and efficacy of clindamycin (1% as clindamycin phosphate) and tretinoin (0.025%) for the treatment of acne vulgaris: a combined analysis of results from six controlled safety and efficacy trials conducted in Europe. Poster P89, American Academy of Dermatology 62nd Annual Meeting, February 6-11, 2004, Washington, DC.

26. Wolf JE, Kaplan D, Kraus S, et al. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blind study. J Am Acad Dermatol. 2003;49(Suppl):S211-S217.